Get startedLog in
    Picture of Apellis Pharmaceuticals logo

    APLS — Apellis Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Apellis Pharmaceuticals Q3 Basic EPS USD -0.46

    Picture of Apellis Pharmaceuticals logoApellis Pharmaceuticals
    05/11/2024 12:05
    Nov 05 (Reuters) - Apellis Pharmaceuticals Q3 operating income USD -47.28
million.
* Q3 product revenue USD 176.571 million
* Q3 operating expenses USD 244.11 million
* Q3 net income USD -57.445 million

    Recent news on Apellis Pharmaceuticals

    See all news